Heart Disease Clinical Trials in Chicago

Showing 341-360 of 511 trials

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

NCT03170219

To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization (days alive and outside the hospital) compared to usual care.

Acute Heart FailureDecompensated Heart Failure

Adrian Hernandez11 participantsStarted Apr 2018

Atlanta, Georgia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +13 more locations

TERMINATED2.2 miles

Global Non-interventional Heart Failure Disease Registry

NCT02595814

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for acute HF.

Acute Heart Failure

Novartis Pharmaceuticals18,805 participantsStarted Jul 2014

San Diego, California, United States • San Francisco, California, United States • Chicago, Illinois, United States +343 more locations

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

Global Non-interventional Heart Failure Disease Registry

Heart Disease Trials in Other Cities

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant

IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting

An Assessment of the Glider Balloon in Complex Lesions

MultiPoint Pacing IDE Study

Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

CANVAS - CANagliflozin cardioVascular Assessment Study

High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)

Detect Fluid Early From Intra-thoracic Impedance Monitoring

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Canadian SCAD Study

Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

MediGuide Registry

Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Vascular Inflammation in Psoriasis - Extension Study

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in Chicago